Navigation Links
Generex Announces Date of Annual Stockholders' Meeting
Date:4/23/2012

WORCESTER, Mass. and TORONTO, April 23, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT.OB) announced today that the next annual meeting of the Generex stockholders will be held at 10 a.m. EDT on Tuesday, June 19, 2012.  The meeting will be held at the Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, Ontario, Canada.  The record date for the meeting is May 2, 2012.

(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b )

About Generex Biotechnology Corporation
Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation in immunotherapy. One of its platform technologies relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
2. Generex Announces Patent Award for its Core Vaccine Technologies in Japan
3. Generex Secures Commitments for $3.6M Capital Raise
4. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
5. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
6. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
7. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
8. Generex Makes Podium Presentation of Clinical Data on Generex Oral-lyn™ at European Association for the Study of Diabetes Annual Meeting
9. Generex Provides Update on Spinout of Antigen Express
10. Generex Augments Cash Position With Sales of Non-Essential Assets
11. Amarantus BioSciences and Generex Biotechnology Collaborate on Cell Therapy for Late Stage Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... BETHESDA, Md. , Oct. 1, 2014 /PRNewswire/ ... committed to the fostering and monetization of intellectual ... Spherix,s litigation against VTech and Uniden in the ... Texas has been rescheduled ... scheduled for October 2, 2014.  The Court Order ...
(Date:10/1/2014)... Irvine, CA (PRWEB) September 30, 2014 ... for user-friendly, cost-effective tools to address sales, training ... PMG has developed innovative mobile applications to ... studies, outlining the agency’s latest customized mobile app ... http://www.studiopmg.com/work . , In partnership with Toyota, ...
(Date:10/1/2014)... The U.S. Department of Labor has ... Edwardsville as part of the Trade Adjustment Assistance Community ... co-administered by the Department of Labor and Department of ... Thomas E. Perez and Secretary of Education Arne Duncan ... grants to nearly 270 colleges across the country. ...
(Date:9/30/2014)... . , Electrical ... a new kind of building block for digital integrated ... be based on three-dimensional arrangements of nanometer-scale magnets instead ... semiconductor industry CMOS fabrication of silicon chips ... the University of Notre Dame are exploring "magnetic computing" ...
Breaking Biology Technology:Markman Hearing Date for VTech and Uniden Litigation Now Set for November 10, 2014 2Digital Agency Studio PMG Launches New Case Studies on Website 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 3U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 4A new dimension for integrated circuits: 3-D nanomagnetic logic 2A new dimension for integrated circuits: 3-D nanomagnetic logic 3
... Esker Software, worldwide leader in ... Esker Fax and VSI-FAX(R) product ... Notes 3.0. This new solution ... communicate more efficiently, effectively, and ...
... often encounter certain genes, chromosomal regions or entire ... CloneSmart technology was designed specifically to eliminate many ... individual gene or a complete genome. The technology ... clone sequences that are difficult to clone with ...
... Information Networks Corporation, a leading Midwest provider of data ... it has been selected by Microsoft as a featured ... Studio .NET 2003 Launch. , , ,Scheduled for ... inMilwaukee, Wisconsin, Berbee will speak in depth about addressing ...
Cached Biology Technology:Molecular Cloning Systems Gets Distributor 2
(Date:9/30/2014)... Evidence of the environmental effects of moorland burning is ... the subject, with the aim of relieving tensions on ... , The EMBER (Effects of Moorland Burning on the ... burning on moorland, which is practised predominantly to support ... impacts on peat hydrology, peat chemistry and physical properties, ...
(Date:9/30/2014)... monkeys have captured the popular attention of both children ... cycle -- sold as dehydrated eggs, these tiny brine ... than a tank of salt water. , Physicists, ... zooplankton, brine shrimp vertically migrate in large groups in ... surface at night and retreating deeper during the day. ...
(Date:9/30/2014)... Medicine reports positive results of a phase 1 ... of lung cancer marked by rearrangement of the gene ... advanced non-small cell lung cancer testing positive for ROS1 ... 3 complete responses and 33 partial responses. Median progression-free ... to resume its growth after being slowed by treatment ...
Breaking Biology News(10 mins):Grouse moor burning causes widespread environmental changes 2Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2
... at the Smithsonian Institution and the Hawaii Institute of ... have created the first frozen bank for Hawaiian corals ... to preserve their diversity in Hawaii. Mary Hagedorn, an ... with the Smithsonian Conservation Biology Institute, leads the laboratory ...
... treatment, also brings debilitating side effects such as nausea, liver ... a new way to deliver this life-saving therapy to cancer ... has been invented by Dr. Dan Peer of Tel ... Center for Nano Science and Nano Technology together with Prof. ...
... More than 120 sturgeon and paddlefish scientists and enthusiasts from ... 2 in Bozeman and at Chico Hot Springs in Montana. ... North American Chapter of the World Sturgeon Conservation Society and ... in North America. The meeting will begin in Bozeman, ...
Cached Biology News:Smithsonian scientists help create first frozen repository for Hawaiian coral 2A cluster bomb for cancer care 2
Homo sapiens MEP50 protein, mRNA...
Mouse H60 Allophycocyanin MAb (Clone 205326) ENTREZ GeneID: 15101...
RAB32, member RAS oncogene family, mRNA (cDNA clone MGC:13500 IMAGE:4280407), complete cds...
EDTA, 0.5 M solution, 100 ml. Ethylene diaminetetraacetic acid.Sterile, nuclease-free. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: